[Definition and mode of action of the psychomotor Parkinson syndrome therapeutically induced by serpasil and largactil].
D000959:Antihypertensive Agents; D002746:Chlorpromazine / Q000494:pharmacology*; D010300:Parkinson Disease / Q000209:etiology*; D012110:Reserpine; D046948:Secologanin Tryptamine Alkaloids / Q000494:pharmacology*
D000959:Antihypertensive Agents; D046948:Secologanin Tryptamine Alkaloids; D012110:Reserpine; D002746:Chlorpromazine
CHLORPROMAZINE/effects; PARALYSIS AGITANS/etiology and pathogenesis; RAUWOLFIA ALKALOIDS/effects
Uber Begriff und Wirkungsweise des therapeutisch erstrebten psychomotorischen Serpasil- (Rauwolfiaalkaloid-) und Largactil-(Megaphen-) Parkinson-Syndroms.